Patents by Inventor John M. Wages, Jr.

John M. Wages, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for using a solid support to purify RNA
    Patent number: 7893228
    Abstract: Reagents, methods and kits for the purification of RNA from biological materials are provided.
    Type: Grant
    Filed: October 12, 2001
    Date of Patent: February 22, 2011
    Assignee: Qiagen North American Holdings, Inc.
    Inventors: Ellen M. Heath, John M. Wages, Jr.
  • Compositions and methods for using a solid support to purify RNA
    Patent number: 7767804
    Abstract: Reagents, methods and kits for the purification of RNA from biological materials are provided.
    Type: Grant
    Filed: October 30, 2006
    Date of Patent: August 3, 2010
    Assignee: Qiagen North American Holdings, Inc.
    Inventors: Robert Jackson Bair, Jr., Ellen M. Heath, Heather Meehan, Kim Elayne Paulsen, John M. Wages, Jr.
  • Compositions and methods for using a solid support to purify RNA
    Patent number: 7148343
    Abstract: Reagents, methods and kits for the purification of RNA from biological materials are provided.
    Type: Grant
    Filed: April 16, 2003
    Date of Patent: December 12, 2006
    Assignee: Gentra Systems, Inc.
    Inventors: Robert Jackson Bair, Jr., Ellen M. Heath, Heather Meehan, Kim Elayne Paulsen, John M. Wages, Jr.
  • Reagent and method for isolation and detection of selected nucleic acid sequences
    Patent number: 6060246
    Abstract: The invention relates to compositions and methods for rapidly detecting or isolating a target nucleic acid sequence in a polynucleotide-containing sample. The sample is exposed to a rapid pairing reagent, which contains a rapid capture component, effective to rapidly and non-selectively bind polynucleotides, and a target specific probe, effective to selectively bind the target nucleic acid sequence. Selectively disrupting the binding between the capture component and polynucleotides leaves only target sequence bound to the rapid pairing reagent.
    Type: Grant
    Filed: November 13, 1997
    Date of Patent: May 9, 2000
    Assignee: AVI BioPharma, Inc.
    Inventors: James E. Summerton, Dwight D. Weller, John M. Wages, Jr.